症状のある外周動脈疾患の患者に対する監督運動療法の実施:アメリカ心臓協会の科学勧告
Circulation
|August 27, 2019
まとめ
監督された運動療法 (SET) は,外周動脈疾患 (PAD) の患者の歩行能力と生活の質を改善します. このガイドは,患者の改善のためのメディケア・メディケイドサービスセンターの基準によるSETプログラムの実施を詳細に説明しています.
科学分野:
- 心血管医学
- リハビリテーション科学
背景:
- 周辺動脈疾患 (PAD) は患者の機能を著しく低下させ,衰えを加速し,生活の質を低下させます.
- 監督運動療法 (SET) は,症状のあるPADに対する実証された介入であり,歩行能力と全体的な状態を改善します.
研究 の 目的:
- 症状のあるPADの患者にSETプログラムを提供するための実践的なガイドを提供すること.
- メディケア・メディケイド・サービスセンター (CMS) の基準,紹介プロセス,SETのカバー要件を概説する.
- SET プロトコルの実施,結果の測定,家庭での運動への移行に関するガイドラインを提供すること.
主な方法:
- このアドバイザリでは,PADのSETに関するCMSのナショナル・カバレッジ・ディテリメーション (CAG-00449N) ガイドラインを要約しています.
- 臨床医と管理者のための 実践的な実施戦略を詳細に説明しています
- ガイドラインには SET プロトコル,結果測定,ホームエクササイズ移行計画が含まれています.
主要な成果:
- SETは,PAD患者の歩行能力,機能的状態,および健康関連の生活の質を明らかに改善します.
- 症状のあるPAD患者に対するSETプログラムでは,CMSの適用が可能です.
- 構造化された実装により,CMSの要件が遵守され,患者の利益が最大化されます.
結論:
- SETはPAD管理の重要な構成要素であり,CMSのカバーによってサポートされています.
- このガイドは,PAD患者のためのSETプログラムの効果的な実施を容易にする.
- CMSのガイドラインに従うことは,PADのメディケア受給者のための有益な運動療法へのアクセスを保証します.
関連する概念動画
Peripheral Artery Disease I: Introduction
324
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
324
Peripheral Artery Disease IV: Nursing Management
354
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
354
Peripheral Artery Disease III: Interprofessional Care
267
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
267
Peripheral Artery Disease V: Postoperative Nursing Management
381
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
381
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
366
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
366
Heart Failure VI: Adjunct Therapies
273
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
273


